# FDA 483 - BASF Corporation - July 22, 2024

Source: https://www.globalkeysolutions.net/records/483/basf-corporation/62f464e2-49f9-4484-b12c-1d3b480f7034

> FDA 483 for BASF Corporation on July 22, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BASF Corporation
- Inspection Date: 2024-07-22
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: An FDA inspection of BASF Corporation in Geismar, LA, an API manufacturer, revealed an observation regarding inadequate investigations. The firm failed to adequately investigate out-of-specification (OOS) iodine occurrences for its active pharmaceutical ingredient (API) PVP-Iodine. These investigations did not address the root cause or evaluate the impact on process controls.

## Related Officers

- [Medical Officer at FDA](https://www.globalkeysolutions.net/people/brittny-c-cargo/a3479241-5390-4ddb-b892-df0bac1c89cf)

Company: https://www.globalkeysolutions.net/companies/basf-corporation/66c1d1cd-8b92-4631-b68d-5e8932ea9c42

Office: https://www.globalkeysolutions.net/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea